000			04166nam a2200277 4500
001			392979
010			_a9291680060
090			_a392979
100			_a20150127d1997 y0pory50 ba
101			_aeng
200			_aEstimating the prevalence of problem drug use in Europe _fEuropean Monitoring Centre for Drugs and Drug Addiction, EMCDDA, Pompidou Group
210			_aLuxembourg _cOffice for Official Publications of the European Communities _d1997
215			_a272 p. _d24 cm
225			_aEMCDDA Scientific Monograph Series _v1
300			_aComunicações provenientes do seminário científico "Addiction Prevalence Estimation: Methods and Research Strategies" que teve lugar em Estrasburgo, França, entre 10 e 14 de Junho de 1996.
330			_aAcknowledgments. General introduction (Richard Hartnoll). Part I - Science and policy: Introduction (Gerry V. Stimson). Chapter 1 - Estimating the scale and nature of drug problems: the relationship between science, policy and drugs strategy (Gerry V. Stimson; Ali Judd). Chapter 2 - The relationship between drug use prevalence estimation and policy interests (Peter D. A. Cohen). Chapter 3 - Policy makers and the use of prevalence data (Philip Lazarov). Part II - Case-finding methods: Introduction (Matthew Hickman). Chapter 4 - Estimating prevalence using the case-finding method: an overview (Roland Simon). Chapter 5 - A case-finding study to estimate the prevalence of heroin users in Navarra, Spain (Conchi Moreno Iribas; Mikel Urtiaga Dominguez). Chapter 6 - Problems of definition and other aspects of case-finding: the Swedish nationwide studies (Börje Olsson). Chapter 7 - Local prevalence estimation: can an inner-city prevalence survey produce useful information? (Paul Griffiths; Michael Farrell; Samantha Howes). Part III - Capture-recapture methods: Introduction (Martin Frischer). Chapter 8 - Estimating the prevalence of drug use using the capture-recapture method: an overview (Antònia Domingo-Salvany). Chapter 9 - Capture-recapture methodology: lessons from studies of animal populations (Clive Richardson). Chapter 10 - A capture-recapture study to estimate the size of the addict population in Toulose, France (Pierre-Yves; Geneviève Chêne). Chapter 11 - More complex capture-recapture models: an illustrative case study using data from Glasgow, Scotland (Martin Frischer). Part IV - Multiplier methods: Introduction (Colin Taylor). Chapter 12 - Estimating the prevalence of drug abuse using the mortality multiplier method: an overview (Martin Frischer). Chapter 13 - Determining the number of drug-related deaths (Klaus Puschel). Chapter 14 - Establishing mortality rates from cohort data (Marina Davoli). Chapter 15 - Drug-related deaths as an indirect indicator, based on the Danish experience (Kenrik Saelan). Part V - Nomination methods: Introduction (Martin Frischer). Chapter 16 - Estimating the prevalence of drug use using nomination techniques: an overview (Colin Taylor). Chapter 17 - The tip of the iceberg: snowball sampling and nomination techniques, the experience of Dutch studies (Dirk J. Korf). Part VI - Combining estimation methods and system dynamics models (Ludwig Kraus). Chapter 19 - Comparison of different estimation methods in the Netherlands (Dirk J. Korf). Chapter 20 - Case finding, capture-recapture and double counting: a Berlin case study (Wolf Kirschner). Chapter 21 - Difficulties in estimating prevalence in Budapest (Zsuzsanna Elekes). Chapter 22 - Comparison of different estimation methods in Poland (Janusz Sieroslawski; Antoni Zielínski). Chapter 23 - Comparison of key informant and multiplier estimates in Slovenia (Dusan Nolimal). Chapter 24 - Cross-validating at local level (Richard Hartnoll). General conclusions (Richard Hartnoll). Contributors.
606			_aDROGA _9228142
606			_aPREVENÇÃO DA TOXICODEPENDÊNCIA _9103892
606			_aESTATÍSTICAS SOBRE DROGA _9344136
606			_aOEDT _9321506
606			_aCOMUNIDADE EUROPEIA _9220383
606			_aEUROPA _9326972
710			_aEUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION _9351987
955			_xOferta